SCHEMBL29399995

SCHEMBL29399995

CCCCC(OC1CCCCO1)C(N)=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 3/20 0.33
ALDH1A1 P00352 3/20 0.33
RAB9A P51151 3/20 0.32
HSD17B10 Q99714 2/20 0.32
METAP1 P53582 1/20 0.32
NPC1 O15118 1/20 0.32
TP53 P04637 1/20 0.32
HPGD P15428 1/20 0.32
USP2 O75604 1/20 0.32
NAAA Q02083 2/20 0.31
MMP1 P03956 1/20 0.31
MMP7 P09237 1/20 0.31
MMP12 P39900 1/20 0.31
ECE1 P42892 1/20 0.31
MMP13 P45452 1/20 0.31
DPP4 P27487 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29870181 0.96 ALDH1A1 (0.34) CA1CA2MEN1KMT2ASMN1; SMN2
SCHEMBL29870007 0.95 NAAA (0.35) MEN1KMT2ASMN1; SMN2ALDH1A1RAB9A
SCHEMBL10704941 0.95 NAAA (0.35) MEN1KMT2ASMN1; SMN2ALDH1A1RAB9A
SCHEMBL29397787 0.92 ALDH1A1 (0.33) MEN1KMT2ASMN1; SMN2ALDH1A1HSD17B10
SCHEMBL8078214 0.89 MAPT (0.33) CA1CA2MEN1KMT2A
SCHEMBL4100097 0.87 CA2 (0.38) CA2MEN1KMT2ASMN1; SMN2RAB9A
SCHEMBL20764818 0.85 MEN1 (0.34) MEN1KMT2AALDH1A1
SCHEMBL9787 0.85 MEN1 (0.34) MEN1KMT2AALDH1A1
SCHEMBL3988416 0.85 CA1 (0.40) CA1CA2MEN1KMT2ARAB9A
SCHEMBL30989292 0.82 MEN1 (0.38) MEN1KMT2ATP53NAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112920167-B Double-target inhibitor targeting FGFR and HDAC, preparation method and application thereof, pharmaceutical composition and medicament 四川大学华西医院 2022-08-26 CN disclosed
WO-2022037365-A1 DOUBLE-TARGET INHIBITOR TARGETING FGFR AND HDAC, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF, PHARMACEUTICAL COMPOSITION AND MEDICAMENT 四川大学华西医院 2022-02-24 WO disclosed